Results for tag: "RSV F Vaccine"

The RSV F Vaccine is a vaccine used to protect against respiratory syncytial virus (RSV) infection. RSV is a common virus that can cause severe respiratory illness in infants and young children. The RSV F Vaccine is a recombinant subunit vaccine, which means it is made from a protein that is found on the surface of the virus. It is approved for use in infants and young children in the United States and other countries. The RSV F Vaccine market is a growing segment of the global vaccine market. It is estimated that the RSV F Vaccine market will reach $1.2 billion by 2025. The market is driven by increasing awareness of the importance of immunization, the availability of new vaccines, and the increasing prevalence of RSV infection. The RSV F Vaccine market is dominated by a few large pharmaceutical companies, including GlaxoSmithKline, Merck, and Pfizer. Other companies in the market include Sanofi Pasteur, AstraZeneca, and Novavax. Show Less Read more